A group of investors including SBCVC and Kexin Capital have backed a $32 million funding round for China’s HaploX Biotechnology.
It follows a RMB50 million ($7.7 million) Series A round in 2016 led by SBCVC. Previous investors also include the Shenzhen Science Technology & Innovation Commission and Beijing Grains Valley Venture...
Shanghai Kechow Pharma, a Chinese small molecule targeted drug developer, has raised a $45 million Series C round led by Decheng Capital.
Kurt Bjorklund, a co-managing partner at Permira, explains how a sector-focused investment style is becoming indispensable in Asia’s competitive and disruption-prone markets
Baibu, a Chinese B2B trading and services platform for the textiles and fabrics industry, has raised a $300 million Series D round led by DST Global.
Food delivery start-up Delivery Hero has agreed to acquire Korean peer Woowa Brothers in a deal that values the target at $4 billion and will facilitate exits for several private equity investors.